Safety Studies for a 44-Channel Suprachoroidal Retinal Prosthesis: A Chronic Passive Study

No prior work had resolved the long-term passive safety profile of high-density retinal implants in animal models. Prior research has shown that earlier prototypes provided limited visual fields for patients. That uncertainty drove the need for an upgraded device with increased electrode counts. It was already known that suprachoroidal placement offers a less invasive surgical approach than other retinal locations. This gap motivated the current investigation into a 44-channel device. Previous studies often lacked the longitudinal data required to confirm device stability within the eye. No prior work had fully characterized the tissue response to this specific high-density array configuration. This study addresses the requirement for preclinical validation before human testing can safely proceed.

The aim was to evaluate the preclinical passive safety characteristics of an upgraded 44-channel suprachoroidal retinal prosthesis. Researchers sought to determine if the increased electrode count would maintain ocular health. This study addresses the need for longitudinal data regarding device stability and tissue response. The investigators wanted to confirm that the array conforms effectively to the retinal curvature. They also aimed to identify potential surgical complications associated with the new hardware design. This work serves as a critical step in verifying the safety profile before human implementation. The team focused on comparing the performance of this device against previous prototypes. Ultimately, the project provides the necessary evidence to support future clinical trials for visual restoration.

The team employed a longitudinal design to monitor ten normal-sighted felines over twenty weeks. Investigators performed unilateral implantation of the array near the area centralis. Review approach involved regular clinical assessments including color fundus photography and optical coherence tomography. Experts also utilized full-field electroretinography to track physiological performance. Intraocular pressure measurements provided additional data on ocular health throughout the duration of the trial. Researchers conducted histopathology on a subset of subjects between thirteen and fifteen weeks post-surgery. This analysis focused on grading inflammation and fibrosis within the surrounding tissue. The final phase included the removal of the hardware to verify the physical integrity of the electrodes.

Eight subjects demonstrated successful array insertion with maintained retinal health throughout the observation period. The device exhibited good conformability to the curvature of the retina in the majority of cases. Mechanical stability remained high, with lateral movement restricted to less than two disc diameters. Four instances of complications arose, including choroidal bulging, systemic hemorrhage, infection, and partial scleral erosion. No changes in retinal structure or function occurred at the study endpoint compared to baseline. Microscopic evaluation revealed only a mild foreign body response to the implanted materials. All electrodes remained intact upon the conclusion of the hardware removal process. These results indicate that the device maintains a stable profile during long-term passive implantation.

The authors propose that the device possesses an acceptable safety profile for future clinical trials. They suggest that the observed complications resulted from anatomical constraints inherent to the feline model. Researchers anticipate that human outcomes will show improved safety compared to these animal findings. The study confirms that the array maintained structural integrity throughout the observation period. Investigators observed only a mild foreign body reaction upon microscopic examination of the tissue. No permanent changes to retinal function occurred following the implantation procedure. The team concludes that the design successfully conforms to the curvature of the eye. These findings support the transition of this technology into human medical research.